CARLSMED, INC. — Form 8-K
Filed September 8, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 42/100
What the filing says
Jeff Bertolini, who joined Carlsmed in September 2024 as Senior Vice President of Operational Excellence, has been promoted to Chief Operating Officer effective immediately. Bertolini previously held senior operations roles at SI-BONE, NuVasive, and US Surgical. CEO Mike Cordonnier credited him with driving deployment of advanced manufacturing technologies and scaling capabilities.
Why this rating
Internal promotion of experienced operations executive; no financial impact disclosed. Positive signal on execution capability but routine for $118M company.
See more from September 8, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.